| US 7,482,379 B2 | ||
| Propenoyl hydrazides | ||
| James C. Powers, Atlanta, Ga. (US); Juliana Asgian, Fullerton, Calif. (US); Özlem Dogan Ekici, Columbus, Ohio (US); Marion Gabriele Gotz, Hirschau (Germany); Karen Ellis James, Cumming, Ga. (US); Zhao Zhao Li, Norcross, Ga. (US); and Brian Rukamp, Greenleaf, Wis. (US) | ||
| Assigned to Georgia Tech Research Corporation, Atlanta, Ga. (US) | ||
| Filed on Feb. 18, 2005, as Appl. No. 11/62,017. | ||
| Claims priority of provisional application 60/545354, filed on Feb. 18, 2004. | ||
| Prior Publication US 2005/0256058 A1, Nov. 17, 2005 | ||
| Int. Cl. A61K 31/15 (2006.01); C07C 243/10 (2006.01) | ||
| U.S. Cl. 514—614 [564/151] | 9 Claims |
1. A compound of the formula:
![]() R1 is selected from the group consisting of M1-AA1, M1-AA2-AA1, and M1-AA3-AA2-AA1;
W is selected from the group consisting of halogen, cyano, and hydrogen;
M1 is selected from the group consisting of H, NH2—CO—, NH2—CS—, NH2—SO2—, X—NH—CO—, X2N—CO—, X—NH—CS—, X2N—CS—, X—NH—SO2—, X2N—SO2—, X—CO—, X—CS—, X—, Y—SO2—, Y—O—CO—, Y—O—CS—, morpholine-CO—, and biotinyl;
X is selected from the group consisting of H, C1-10 alkyl, C3-15 cyclized alkyl, C1-10 fluoroalkyl, C1-10 alkyl substituted with J, C1-10 fluoroalkyl substituted with J, 1-admantyl, 9-fluorenyl, phenyl, pentafluorophenyl, phenyl monosubstituted with K, phenyl
disubstituted with K, phenyl trisubstituted with K, naphthyl, naphthyl monosubstituted with K, naphthyl disubstituted with
K, naphthyl trisubstituted with K, C1-10 fluoroalkyl with an attached phenyl group, C1-10 alkyl with an attached phenyl group, C1-10 alkyl with two attached phenyl groups, C1-10 alkyl with an attached phenyl group substituted with K, C1-10 alkyl with two attached phenyl groups substituted with K, C1-10 alkyl with an attached naphthyl group, C1-10 alkyl with an attached naphthyl group substituted with K, C1-10 alkyl with an attached phenoxy group, and C1-10 alkyl with an attached phenoxy group substituted with K on the phenoxy group;
Y is selected from the group consisting of C1-10 alkyl, C3-15 cyclized alkyl, C1-10 fluoroalkyl, C1-10 alkyl substituted with J, C1-10 fluoroalkyl substituted with J, 1-admantyl, 9-fluorenyl, phenyl, phenyl monosubstituted with K, phenyl disubstituted with
K, phenyl trisubstituted with K, naphthyl, naphthyl monosubstituted with K, naphthyl disubstituted with K, naphthyl trisubstituted
with K, C1-10 fluoroalkyl with an attached phenyl group, C1-10 alkyl with an attached phenyl group, C1-10 alkyl with two attached phenyl groups, C1-10 alkyl with an attached phenyl group substituted with K, C1-10 alkyl with two attached phenyl groups substituted with K, C1-10 alkyl with an attached naphthyl group, C1-10 alkyl with an attached naphthyl group substituted with K, C1-10 alkyl with an attached phenoxy group, and C1-10 alkyl with an attached phenoxy group substituted with K on the phenoxy group;
J is selected from the group consisting of halogen, CO2H, OH, CN, NO2, amino, C1-10 alkoxy, C1-10 alkylamino, C2-12 dialkylamino, C1-10 alkyl-O—CO—, C1-10 alkyl-O—CO—NH—, and C1-10 alkyl-S—;
K is selected from the group consisting of halogen, C1-10 alkyl, C1-10 perfluoroalkyl, C1-10 alkoxy, phenoxy, NO2, CN, OH, CO2H, CONH2, amino, C1-10 alkylamino, C2-12 dialkylamino, C1-10 acyl, and C1-10 alkoxy-CO—, and C1-10 alkyl-S—;
AA1, AA2, and AA3 are side chain blocked or unblocked amino acids with the L configuration, D configuration, or no chirality at the alpha-carbon
selected from the group consisting of alanine, valine, leucine, isoleucine, proline, methionine, methionine sulfoxide, phenylalanine,
tryptophan, glycine, serine, threonine, cysteine, tyrosine, asparagine, glutamine, aspartic acid, glutamic acid, lysine, arginine,
histidine, phenylglycine, beta-alanine, norleucine, norvaline, alpha-aminobutanoic acid, epsilon-aminocaproic acid, citrulline,
hydroxyproline, ornithine, homoarginine, sarcosine, indoline 2-carboxylic acid, 2-azetidinecarboxylic acid, pipecolinic acid
(2-piperidine carboxylic acid), O-methylserine, O-ethylserine, S-methylcysteine, S-ethylcysteine, S-benzylcysteine, NH2—CH(CH2CHEt2)—CO2H, alpha-aminoheptanoic acid, NH2—CH(CH2-1-naphthyl)-CO2H, NH2—CH(CH2-2-naphthyl)-CO2H, NH2—CH(CH2CH2CH2-phenyl)-CO2H, NH2—CH(CH2-cyclohexyl)-CO2H, NH2—CH(CH2-cyclopentyl)-CO2H, NH2—CH(CH2-cyclobutyl)—CO2H, NH2—CH(CH2-cyclopropyl)-CO2H, trifluoroleucine, 4-fluorophenylalanine, lysine substituted on the epsilon nitrogen with a biotinyl group, hexafluoroleucine,
![]() R2 is selected from the group consisting of C1-10 alkyl, C1-10 perfluoroalkyl, C1-10 alkyl substituted with Q, C1-10 alkyl substituted with phenyl, C1-10 alkyl with an attached phenyl substituted with K, C1-10 alkyl substituted with naphthyl, C1-10 alkyl with an attached naphthyl substituted with K, phenyl, phenyl substituted with K, naphthyl, naphthyl substituted with
K, C1-10 alkyl substituted with CONH2, C1-10 alkyl substituted with CONHR5, C1-10 alkyl substituted with CO2H, C1-10 alkyl substituted with SO2NH2, C1-10 alkyl substituted with SO3H, 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-furyl substituted with K, 3-furyl substituted with K, 2-thienyl substituted with
K, 3-thienyl substituted with K, 2-furyl substituted with G, 3-furyl substituted with G, 2-thienyl substituted with G, 3-thienyl
substituted with G, C1-10 alkyl substituted with CO2R5, CH2CH2SCH3, CH2-3-indolyl, C1-2 alkyl with an attached 2-furyl, C1-2 alkyl with an attached 3-furyl, C1-2 alkyl with an attached 2-thienyl, C1-2 alkyl with an attached 3-thienyl, C1-2 alkyl with an attached 2-furyl substituted with K, C1-2 alkyl with an attached 3-furyl substituted with K, C1-2 alkyl with an attached 2-thienyl substituted with K, C1-2 alkyl with an attached 3-thienyl substituted with K, C1-2 alkyl with an attached 2-furyl substituted with G, C1-2 alkyl with an attached 3-furyl substituted with G, C1-2 alkyl with an attached 2-thienyl substituted with G, C1-2 alkyl with an attached 3-thienyl substituted with G, CH2-2-imidazyl, C1-10 alkyl substituted with G, C1-10 alkyl with an attached phenyl substituted with G, C1-10 alkyl with an attached naphthyl substituted with G, phenyl substituted with G, and naphthyl substituted with G;
R5 is selected from the group consisting of C1-10 alkyl and C1-10 alkyl substituted with phenyl;
Q is selected independently from the group consisting of C1-10 alkoxy, C1-10 alkyl-S—, C1-10 alkoxy substituted with phenyl, and C1-10 alkyl-S-substituted with phenyl;
G is selected from the group consisting of cyano, amidino (—C(═NH)NH2), guanidino (—NHC(═NH)NH2), isothiureido (—S—C(═NH)NH2), amino, C1-6 alkylamino, C2-12 dialkylamino, and imidazyl;
R3 is selected independently from the group consisting of H, R6, halogen, CN, CO—C6H5, benzoyl substituted with K on the phenyl, CO2H, CO2R7, CONHR8, CONR8R9, CO-AA4-T,
![]() R4 is selected from the group consisting of R6, halogen, CN, CO—C6H5, benzoyl substituted with K on the phenyl, CO2H, CO2R7, CONHR8, CONR8R9, CO-AA4-T,
![]() R6 is selected independently from the group consisting of phenyl, phenyl monosubstituted with K, phenyl disubstituted with K,
phenyl trisubstituted with K, naphthyl, naphthyl monosubstituted with K, naphthyl disubstituted with K, naphthyl trisubstituted
with K, C1-10 alkenyl, C3-15 cyclized alkyl, C1-10 alkyl with a phenyl group attached to the C1-10 alkyl, C3-15 cyclized alkyl with an attached phenyl group, C1-10 alkyl with an attached phenyl group monosubstituted with K, C1-10 alkyl with an attached phenyl group disubstituted with K, C1-10 alkyl with an attached phenyl group trisubstituted with K, C3-15 cyclized alkyl with an attached phenyl group substituted with K, C1-10 alkyl with a naphthyl group attached to the C1-10 alkyl, C3-15 cyclized alkyl with an attached naphthyl group, C1-10 alkyl with an attached naphthyl group monosubstituted with K, C1-10 alkyl with an attached naphthyl group disubstituted with K, C1-10 alkyl with an attached naphthyl group trisubstituted with K, C3-15 cyclized alkyl with an attached naphthyl group substituted with K, C1-10 alkyl with an attached 2-furyl group, C1-10 alkyl with an attached 3-furyl group, C1-10 alkyl with an attached 2-pyridyl group, C1-10 alkyl with an attached 3-pyridyl group, C1-10 alkyl with an attached 4-pyridyl group, 2-furyl, 3-furyl, 2-pyridyl, 3-pyridyl, and 4-pyridyl;
R7 is selected independently from the group consisting of phenyl, phenyl monosubstituted with K, phenyl disubstituted with K,
phenyl trisubstituted with K, naphthyl, naphthyl monosubstituted with K, naphthyl disubstituted with K, naphthyl trisubstituted
with K, C1-10 alkyl, C1-10 alkenyl, C3-15 cyclized alkyl, C1-10 alkyl with a phenyl group attached to the C1-10 alkyl, C3-15 cyclized alkyl with an attached phenyl group, C1-10 alkyl with an attached phenyl group substituted with K, C1-10 alkyl with an attached phenyl group disubstituted with K, C1-10 alkyl with an attached phenyl group trisubstituted with K, C3-15 cyclized alkyl with an attached phenyl group monosubstituted with K, C3-15 cyclized alkyl with an attached phenyl group disubstituted with K, C3-15 cyclized alkyl with an attached phenyl group trisubstituted with K, C1-10 alkyl with a naphthyl group attached to the C1-10 alkyl, C3-15 cyclized alkyl with an attached naphthyl group, C1-10 alkyl with an attached naphthyl group monosubstituted with K, C1-10 alkyl with an attached naphthyl group disubstituted with K, C1-10 alkyl with an attached naphthyl group trisubstituted with K, C3-15 cyclized alkyl with an attached naphthyl group monosubstituted with K, C3-15 cyclized alkyl with an attached naphthyl group disubstituted with K, C3-15 cyclized alkyl with an attached naphthyl group trisubstituted with K, C1-10 alkyl with an attached 2-furyl group, C1-10 alkyl with an attached 3-furyl group, C1-10 alkyl with an attached 2-pyridyl group, C1-10 alkyl with an attached 3-pyridyl group, and C1-10 alkyl with an attached 4-pyridyl group;
T is selected independently from the group consisting of OH, OR10, NHR11, and NR10R11;
AA4 is a side chain blocked or unblocked amino acid with the L configuration, D configuration, or no chirality at the alpha-carbon
selected from the group consisting of alanine, valine, leucine, isoleucine, proline, methionine, methionine sulfoxide, phenylalanine,
tryptophan, glycine, serine, threonine, cysteine, tyrosine, asparagine, glutamine, aspartic acid, glutamic acid, lysine, arginine,
histidine, phenylglycine, beta-alanine, norleucine, norvaline, alpha-aminobutanoic acid, epsilon-aminocaproic acid, citrulline,
hydroxyproline, ornithine, homoarginine, sarcosine, indoline 2-carboxylic acid, 2-azetidinecarboxylic acid, pipecolinic acid
(2-piperidine carboxylic acid), O-methylserine, O-ethylserine, S-methylcysteine, S-ethylcysteine, S-benzylcysteine, NH2—CH(CH2CHEt2)-CO2H, alpha-aminoheptanoic acid, NH2—CH(CH2-1-naphthyl)-CO2H, NH2—CH(CH2-2-naphthyl)-CO2H, NH2—CH(CH2CH2CH2-phenyl)-CO2H, NH2—CH(CH2-cyclohexyl)-CO2H, NH2—CH(CH2-cyclopentyl)-CO2H, NH2—CH(CH2-cyclobutyl)-CO2H, NH2—CH(CH2-cyclopropyl)-CO2H, trifluoroleucine, 4-fluorophenylalanine, lysine substituted on the epsilon nitrogen with a biotinyl group, hexafluoroleucine,
and
![]() R8 and R9 are selected independently from the group consisting of H, C1-10 alkyl, C1-10 alkenyl, C3-20 cyclized alkyl, C1-10 alkyl with a phenyl group attached to the C1-10 alkyl, C1-10 alkyl with two phenyl groups attached to the C1-10 alkyl, C3-20 cyclized alkyl with an attached phenyl group, phenyl, phenyl substituted with K, C1-10 alkyl with an attached phenyl group substituted with K, C1-10 alkyl with an attached phenyl group disubstituted with K, C1-10 alkyl with an attached phenyl group trisubstituted with K, C1-10 alkyl with two phenyl groups attached to the C1-10 alkyl and substituted with K on the phenyl group, C1-10 alkyl with two phenyl groups attached to the C1-10 alkyl and disubstituted with K on the phenyl groups, C3-20 cyclized alkyl with an attached phenyl group substituted with K, C1-10 alkyl with a morpholine [—N(CH2CH2)O] ring attached through nitrogen to the alkyl, C1-10 alkyl with a piperidine ring attached through nitrogen to the alkyl, C1-10 alkyl with a pyrrolidine ring attached through nitrogen to the alkyl, C1-20 alkyl with an OH group attached to the alkyl, —CH2CH2CH2OCH3, C1-10 alkyl substituted by 1-naphthyl, C1-10 alkyl substituted by 2-naphthyl, C1-10 alkyl with an attached cyclohexyl group, —NH—CH2CH2-(4-hydroxyphenyl), —NH—CH2CH2-(3-indolyl), C1-10 alkyl with an attached 2-furyl group, C1-10 alkyl with an attached 3-furyl group, C1-10 alkyl with an attached 2-pyridyl group, C1-10 alkyl with an attached 3-pyridyl group, C1-10 alkyl with an attached 4-pyridyl group, and C1-5 alkyl with an attached phenyl and a hydroxyl attached to the C1-5 alkyl;
R10 and R11 are selected independently from the group consisting of H, C1-10 alkyl, phenyl, nitrophenyl, and C1-10 alkyl substituted with phenyl;
or a pharmaceutically acceptable salt, pharmaceutically derivative, hydrate or solvate thereof.
|